Wedbush Securities’s Merck MRK Stock Holding History

Wedbush Securities’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.68M	Sell	51,952 -3,292	-6%	-$385K	0.17%	85
2026 Q1	$6.64M	Buy	55,244 +1,772	+3%	+$205K	0.19%	74
2025 Q4	$5.63M	Sell	53,472 -393	-0.7%	-$36.9K	0.16%	87
2025 Q3	$4.52M	Sell	53,865 -3,352	-6%	-$276K	0.15%	98
2025 Q2	$4.53M	Sell	57,217 -4,420	-7%	-$351K	0.16%	96
2025 Q1	$5.53M	Sell	61,637 -6,197	-9%	-$579K	0.2%	75
2024 Q4	$6.75M	Buy	67,834 +1,834	+3%	+$189K	0.24%	63
2024 Q3	$7.5M	Sell	66,000 -15,863	-19%	-$1.88M	0.28%	54
2024 Q2	$10.1M	Sell	81,863 -2,529	-3%	-$326K	0.36%	40
2024 Q1	$11.1M	Buy	84,392 +8,581	+11%	+$1.06M	0.42%	35
2023 Q4	$8.27M	Buy	75,811 +1,863	+3%	+$193K	0.37%	45
2023 Q3	$7.61M	Buy	73,948 +1,188	+2%	+$128K	0.38%	45
2023 Q2	$8.4M	Buy	72,760 +386	+0.5%	+$43.8K	0.4%	32
2023 Q1	$7.7M	Sell	72,374 -2,221	-3%	-$240K	0.39%	38
2022 Q4	$8.28M	Buy	74,595 +503	+0.7%	+$51.4K	0.45%	28
2022 Q3	$6.38M	Sell	74,092 -12,891	-15%	-$1.15M	0.36%	42
2022 Q2	$7.93M	Sell	86,983 -256	-0.3%	-$22.7K	0.43%	37
2022 Q1	$7.16M	Buy	87,239 +1,058	+1%	+$83.4K	0.33%	48
2021 Q4	$6.61M	Sell	86,181 -1,989	-2%	-$158K	0.28%	51
2021 Q3	$6.62M	Buy	88,170 +551	+0.6%	+$41.9K	0.31%	49
2021 Q2	$6.81M	Buy	87,619 +14,715	+20%	+$1.09M	0.32%	47
2021 Q1	$5.36M	Buy	72,904 +22,626	+45%	+$1.67M	0.3%	51
2020 Q4	$3.92M	Sell	50,278 -111	-0.2%	-$8.49K	0.34%	56
2020 Q3	$3.99M	Buy	50,389 +1,283	+3%	+$100K	0.38%	50
2020 Q2	$3.62M	Buy	49,106 +4,644	+10%	+$350K	0.34%	59
2020 Q1	$3.26M	Sell	44,462 -3,730	-8%	-$293K	0.39%	52
2019 Q4	$4.18M	Buy	48,192 +7,983	+20%	+$656K	0.37%	52
2019 Q3	$3.23M	Buy	40,209 +722	+2%	+$57.9K	0.32%	64
2019 Q2	$3.16M	Buy	39,487 +1,664	+4%	+$127K	0.32%	58
2019 Q1	$3M	Sell	37,823 -8,575	-18%	-$641K	0.32%	60
2018 Q4	$3.38M	Buy	46,398 +1,384	+3%	+$97.7K	0.43%	44
2018 Q3	$3.05M	Buy	45,014 +685	+2%	+$43.6K	0.35%	52
2018 Q2	$2.57M	Buy	44,329 +468	+1%	+$26.4K	0.32%	57
2018 Q1	$2.28M	Buy	43,861 +805	+2%	+$43.5K	0.3%	68
2017 Q4	$2.31M	Buy	43,056 +11,761	+38%	+$652K	0.28%	73
2017 Q3	$1.91M	Sell	31,295 -2,867	-8%	-$174K	0.25%	82
2017 Q2	$2.09M	Sell	34,162 -23	-0.1%	-$1.4K	0.27%	76
2017 Q1	$2.07M	Sell	34,185 -1,712	-5%	-$104K	0.28%	66
2016 Q4	$2.02M	Sell	35,897 -1,473	-4%	-$86.2K	0.3%	63
2016 Q3	$2.23M	Sell	37,370 -6,874	-16%	-$402K	0.33%	58
2016 Q2	$2.43M	Buy	44,244 +454	+1%	+$24.2K	0.4%	50
2016 Q1	$2.21M	Buy	43,790 +2,234	+5%	+$109K	0.38%	51
2015 Q4	$2.09M	Buy	41,556 +14,379	+53%	+$725K	0.38%	54
2015 Q3	$1.28M	Sell	27,177 -599	-2%	-$31.8K	0.26%	86
2015 Q2	$1.51M	Sell	27,776 -823	-3%	-$46.2K	0.28%	75
2015 Q1	$1.57M	Buy	28,599 +308	+1%	+$17.4K	0.27%	82
2014 Q4	$1.53M	Sell	28,291 -1,366	-5%	-$76.1K	0.24%	87
2014 Q3	$1.68M	Buy	29,657 +2,367	+9%	+$133K	0.26%	76
2014 Q2	$1.51M	Sell	27,290 -3,685	-12%	-$201K	0.24%	89
2014 Q1	$1.68M	Sell	30,975 -6,430	-17%	-$333K	0.29%	77
2013 Q4	$1.79M	Sell	37,405 -12,965	-26%	-$593K	0.42%	58
2013 Q3	$2.29M	Buy	50,370 +493	+1%	+$22.5K	0.6%	32
2013 Q2	$2.21M	Buy	+49,877	New	+$2.23M	0.61%	32

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wedbush Securities's MRK Position: Q2 2026 in Review

Wedbush Securities reduced its Merck (MRK) stake by 6% in Q2 2026, selling an estimated $385K and leaving 51,952 shares worth $6.68M. The position accounts for 0.17% of the portfolio, ranked #85.

Wedbush Securities first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.1M in Q1 2024. 1,648 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Wedbush Securities held 51,952 shares of Merck worth $6.68M as of Q2 2026.
Wedbush Securities sold 3,292 Merck shares in Q2 2026, an estimated $385K.
Merck made up 0.17% of Wedbush Securities's portfolio in Q2 2026, its #85 holding.
Wedbush Securities first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Wedbush Securities's Merck position peaked at $11.1M in Q1 2024.
1,648 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.